The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (“health care companies”). It is non-diversified.
Harbor Health Care ETF (MEDI) · Issued by Harbor
| LLY | Eli Lilly and Co | 18.82% |
| ASND | Ascendis Pharma AS | 14.88% |
| RYTM | Rhythm Pharmaceuticals Inc | 4.13% |
| GILD | Gilead Sciences Inc | 3.86% |
| ARGX | argenx SE ADR | 2.92% |
| ABBV | AbbVie Inc | 2.75% |
| NTRA | Natera Inc | 2.62% |
| INSM | Insmed Inc | 2.60% |
| BSX | Boston Scientific Corp | 2.53% |
| PODD | Insulet Corp | 2.24% |
No recent news for MEDI. The ingest cron pulls every 15 minutes during market hours.